User Tools

Site Tools


vaccines

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
vaccines [2021/06/13 10:04]
gary1 [modern vaccines]
vaccines [2021/06/13 10:29] (current)
gary1 [modern vaccines]
Line 186: Line 186:
       * said to be 70-90% in those under 55yrs (90% if booster given) effective in preventing symptomatic infection, none required hospitalisation although only 30 became infected in the trial of over 11,000 studied       * said to be 70-90% in those under 55yrs (90% if booster given) effective in preventing symptomatic infection, none required hospitalisation although only 30 became infected in the trial of over 11,000 studied
       * Aust. has ordered 3.8million doses       * Aust. has ordered 3.8million doses
-      * around 1 in 100,000 will develop [[TSS]]+      * around 1 in 100,000 will develop [[TTS]]
       * less than 1 in 10 million may develop capillary leak syndrome ([[SCLS]]) - mainly women with a PH SCLS - 6 documented cases including 1 death from 78 million doses       * less than 1 in 10 million may develop capillary leak syndrome ([[SCLS]]) - mainly women with a PH SCLS - 6 documented cases including 1 death from 78 million doses
     *Johnson and Johnson Covid-19 vaccine     *Johnson and Johnson Covid-19 vaccine
       * similar to Astra Zeneka       * similar to Astra Zeneka
-      * around 1 in 100,000 will develop [[TSS]]+      * around 1 in 100,000 will develop [[TTS]]
     *Sputnik V vaccine     *Sputnik V vaccine
       * Russia announced roll out of vaccination on 10th Dec 2020       * Russia announced roll out of vaccination on 10th Dec 2020
vaccines.txt ยท Last modified: 2021/06/13 10:29 by gary1